Literature DB >> 9267006

Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments.

D Koletzki1, A Zankl, H R Gelderblom, H Meisel, A Dislers, G Borisova, P Pumpens, D H Krüger, R Ulrich.   

Abstract

Because of its particular immunological properties, the core protein of hepatitis B virus (HBcAg) has become one of the favoured 'virus-like particles' for use as a carrier of foreign epitopes. A new strategy to construct core particles presenting extended foreign protein segments was established based on the introduction of a linker containing a translational stop codon between sequences encoding a C-terminally truncated HBcAg (HBcAg delta) and a foreign protein sequence. Expression in an Escherichia coli suppressor strain allowed the simultaneous synthesis of both HBcAg delta and a read-through fusion protein containing a part of the hantavirus nucleocapsid protein. After purification, the presence of core-like mosaic particles with HBc and hantavirus antigenicity was demonstrated by electron microscopy and immunological tests. This strategy of partial stop codon suppression should improve the use of HBcAg as a carrier of foreign epitopes by allowing insertion of long foreign sequences into particle-forming proteins. The resulting mosaic particles should be of general interest for further vaccine developments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267006     DOI: 10.1099/0022-1317-78-8-2049

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Expression, purification, crystallization and preliminary X-ray crystallographic studies of hepatitis B virus core fusion protein corresponding to octahedral particles.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-31

2.  Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Authors:  Indulis Cielens; Ludmila Jackevica; Arnis Strods; Andris Kazaks; Velta Ose; Janis Bogans; Paul Pumpens; Regina Renhofa
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.860

Review 3.  Progress on the Prevention and Treatment of Hantavirus Disease.

Authors:  Rebecca L Brocato; Jay W Hooper
Journal:  Viruses       Date:  2019-07-04       Impact factor: 5.048

Review 4.  Novel foods to treat food allergy and gastrointestinal infection.

Authors:  Hilary A Perr
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 5.  Novel foods to treat food allergy and gastrointestinal infection.

Authors:  Hilary A Perr
Journal:  Curr Gastroenterol Rep       Date:  2004-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.